<?php
$localizer = "./";
?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
    "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
	xmlns="http://www.w3.org/1999/xhtml">
<!-- InstanceBegin template="/Templates/projects.dwt" codeOutsideHTMLIsLocked="false" -->
<head>
<?php require $localizer . 'includes/head_const.inc.php'?>
<title>Molecular Imaging Center - University of Torino - Projects</title>
<meta name="description" content="" />
</head>
<body>

	<div id='section5'>
	<?php require($localizer . 'includes/main-nav.php'); ?>
		<div id='header'></div>
		<!-- InstanceBeginEditable name="subsection opening" -->
		<div id='subsection0'>
			<!-- InstanceEndEditable -->
			<div id='sidebar'>
				<div class='padding'>
					<!--<dl id='list'></dl>-->
				</div>
			</div>
			<div id='content'>
				<div class='paddingOuter'>
					<div class='band'>
						<h1 class='subsectionTitle'>
							<!-- InstanceBeginEditable name="subsection title" -->
							On going Projects
							<!-- InstanceEndEditable -->
						</h1>
					</div>
					<div class='paddingInner'>
						<!-- InstanceBeginEditable name="subsection content" -->
						<!-- <h1>EU Projects</h1> -->
						<ul>
							<li class="myHoverPlace"><strong><a
									href='http://www.primogaia.eu/'> <span class='paperTitle'>PRIMOGAIA</span></a></strong>
								project "Prepolarized MRI at Earth Field to seek new contrasts
								linked to molecular events for very early detection of
								pathologies" - <strong>H2020-EU.1.2.1. - FET Open</strong>
								(01/12/2019 - 31/05/2023)
								<div class="hide">
									Magnetic Resonance Imaging (MRI) is a non-invasive technology
									that generates high-resolution images of tissues and organs.
									Since its first use on a human being, over 40 years ago, it has
									become instrumental in the diagnosis and monitoring of disease
									and injury. Functional MRI, invented in 1991, is based on the
									same principles but images metabolic activity indirectly via
									changes in blood flow. Its use has led to remarkable
									discoveries in biomedical research. Now, PRIMOGAIA is
									exploiting MRI technology to map and quantify enzyme activity
									in pathological tissue. Enzymes play critical roles in cellular
									metabolism and are already valuable biomarkers of pathology in
									blood tests. Now, their high-resolution spatial localisation in
									tissues will significantly enhance disease detection and
									monitoring. <br> PrimoGaia brings together an interdisciplinary
										consortium of research teams from 4 academics: Aix-Marseille
										University, Universit&eacute; de Mons, Universit&aacute;
										Torino (reagents), CNRS Bordeaux (EPR unit, sequences,
										biology); Fraunhofer Institute (Physics) and 2 companies: <a
										href='https://www.stelar.it/'>Stelar</a> (magnetic unit) and <a
										href='https://www.pure-devices.com/'>Pure Devices</a> an
										innovative SME (MRI instrumentation).
								
								</div></li>
						</ul>
					</div>
								
								<div class='band'>
						<h1 class='subsectionTitle'>
							<!-- InstanceBeginEditable name="subsection title" -->
							Past Projects
							<!-- InstanceEndEditable -->
						</h1>
					</div>
					<div class='paddingInner'>
						<ul>
							<li class="myHoverPlace"><strong><a href='https://phase1.attract-eu.com/showroom/project/monitoring-tissue-implants-by-field-cycling-mri-of-quadrupolar-peak-contrast-agents-acronym-qp-mri/' ><span class='paperTitle'>Attract QPMRI</span></a></strong> project 
							"Monitoring tissue implants by field-cycling MRI of quadrupolar-peak contrast agents" - 
								(20/05/2019 - 31/10/2020)
								<div class="hide">This project aims at developing innovative biocompatible sensors able to monitor 
								the status of tissue implants in vivo, at human scale. These sensors are aimed at reporting on the 
								degradation of the scaffold and on the overall transplanted cells conditions. They represent a 
								completely new class of MRI contrast agents that display remarkable relaxation effects on tissue 
								water protons. Their detection requires the acquisition of images at variable magnetic field strength 
								as provided by Fast Field Cycling MRI (FFCMRI) scanners.
								<br>Consortium: University of Torino and University of Aberdeen.</div></li>	
								
								<li>National project funded by San Paolo Foundation: "Imaging extracellular pH as a MRI
									diagnostic tool" - <strong>CSTO165925</strong>
								(2017-2019);
							</li>
							<li><strong>H2020-MSCA-ITN-2017</strong> project "Zero and
								ultra-low field nuclear magnetic resonance" - <strong><a
									href='https://cordis.europa.eu/project/id/766402'><span
										class='paperTitle'>ZULF</span></a></strong> (2018-2022)</li>
							<li>National project funded by San Paolo Foundation: "Imaging
								extracellular pH as a MRI diagnostic tool" - <strong>CSTO165925</strong>
								(2017-2019);
							</li>
							<li>National project funded by San Paolo Foundation: "Gd retention in brain after Contrast Enhanced MRI" - <strong>CSTO160182</strong>
								(2017-2019);
							</li>
							<li>National project funded by San Paolo Foundation: "MRI guided therapy for combating ovarian cancer" - <strong>CSTO165439</strong>
								(2017-2019);
							</li>
							<li>National project funded by San Paolo Foundation: "Hyperpolarized metabolites for MRI of cancer" - <strong>CSTO164550</strong>
								(2017-2019);
							</li>
							<li><strong>H2020-PHC-2015 project</strong>: "Improving Diagnosis
								by Fast Field-Cycling MRI" - <strong><a href='http://www.identify-project.eu/' ><span class='paperTitle'>Identify</span></a></strong>
								(2016-2020)</li>
							<li><strong>H2020-PHC-2015 project</strong>: "In Vivo Spectral
								Photon Counting CT Molecular Imaging in Cardio- and
								Neuro-Vascular Diseases" - <strong><a href='https://cordis.europa.eu/project/id/668142' ><span class='paperTitle'>SPCCT</span></a></strong> (2016-2020)</li>
							<li><strong>H2020-PHC-2015 project</strong>: "GlucoCEST Imaging
								of Neoplastic Tumours" - <strong><a href='http://www.glint-project.eu/' ><span class='paperTitle'>GLINT</span></a></strong> (2016-2020)</li>
							<li><strong>H2020 INFRADEV-1-2015-2</strong>: "Coordinated
								Research Infrastructures Building Enduring Life-science
								services" <strong><a href='http://www.corbel-project.eu/home.html' ><span class='paperTitle'>CORBEL</span></a></strong> (2015-2019)</li>
							<li>National project <strong>F.E.S.R. 2014/2020</strong>, "Green
								Factory for Composites" (2017-2019)
							</li>
							<li><strong>H2020-INFRASUPP-2014-2</strong>: <strong><a href='http://www.eurobioimaging.eu/global-bioimaging/' ><span class='paperTitle'>Global BioImaging Project</span></a></strong> - International imaging infrastructure services for the
								life science community, 2016-2018</li>
							<li><strong>H2020-INFRADEV-1-2015-2</strong>: "Euro-BioImaging
								Preparatory Phase 2", 2015-2017 (<strong><a
									href='http://www.eurobioimaging.eu/prep-phase2016'><span
										class='paperTitle'>EuBI PP2</span></a></strong>)</li>
							<li>Research project of the Green Chemistry Cluster: "Development
								of second generation technologies for the conversion of organic
								derivatives in green dicarboxylic acids, as building blocks of
								renewable origin for the synthesis of chemicals and polymers" -
								<strong>LIDIA</strong> (2014-2017).
							</li>
							<li><strong>FP7-HEALTH-2013 (602306)</strong>: "Closed-loop
								Molecular Environment for Minimally Invasive Treatment of
								Patients with Metastatic Gastrointestinal Stromal Tumours" - <a
								href='https://cordis.europa.eu/project/id/653212'><span
									class='paperTitle'>MITIGATE</span></a> (2013-2017)</li>
							<li>Integrated EU Project "Imaging of Neuroinflammation in
								Neurodegenerative Diseases" - <strong><a
									href='https://cordis.europa.eu/project/id/278850'><span
										class='paperTitle'>InMIND</span></a></strong> (2012-2017);
							</li>
							<li>National project <strong>AIRC IG2013</strong>: "Dual
								MRI-Optical imaging agents in prostatectomy" (2014-2016);
							</li>
							<li>National <strong>PRIN</strong> project "Innovative chemical
								tools for improved molecular approaches in biomedicine"
								(2013-2015);
							</li>
							<li>National project funded by San Paolo Foundation: "Innovative
								Nanosized Theranostic Agents: design, preparartion and
								preclinical in vivo validation" - <strong>INTA</strong>
								(2012-2015);
							</li>
							<li><strong><a href='https://www.cost.eu/actions/CA16103/'><span
										class='paperTitle'>CA COST Action CA16103</span></a></strong>
								"Magnetic Resonance Imaging Biomarkers for Chronic Kidney
								Disease"</li>
							<li><strong><a href='https://www.cost.eu/actions/TD1004/'><span
										class='paperTitle'>COST Action TD1004</span></a></strong>
								"Theragnostics Imaging and Therapy" (2011-2015)</li>
							<li><strong>FP7-INFRASTRUCTURES-2010-1</strong>: Euro-BioImaging
								- Research infrastructure for imaging technologies in biological
								and biomedical sciences, 2012-2014</li>
							<li>National project funded by San Paolo Foundation: "Validation
								of VHH type molecules and aptamers for the tumor-specific
								release of drugs and the contextual evaluation of the response
								by focused functional imaging" (2012-2014)</li>
							<li>National <strong>POR-FESR 2007-13</strong> project "Solid
								Lipidic Nanoparticles for Imaging Atheroschlerotic Plaques" - <strong>ATHIMAG</strong>
								(2011-2013);
							</li>



							<li><a href="https://cordis.europa.eu/project/id/503569"
								rel="external">Network of Excellence <strong>EMIL</strong>(European
									Molecular Imaging Laboratories) (combating cancer), 2004-2009
							</a></li>
							<li><a href="https://cordis.europa.eu/project/id/512146"
								rel="external">Network of Excellence <strong>DiMI</strong>(Diagnosis
									for Molecular Imaging), 2005-2010
							</a></li>
							<li><strong>STREP</strong> "Ortho/Para-Water", 2004-2008 (Coord.)
							</li>
							<li><a href="http://www.meditrans-ip.net/" rel="external">Integrated
									Project <strong>Meditrans</strong>("Imaging Drug Delivery"),
									2006-2010
							</a></li>
							<li><a href="https://cordis.europa.eu/project/id/201842"
								rel="external">Integrated Project <strong>ENCITE</strong>("Cellular
									Therapy"), 2008-2012
							</a></li>
							<li><strong>COST</strong> "Lanthanides in Diagnosis and Therapy",
								2001-2006 (Coord.)</li>
							<li><a href="https://www.cost.eu/actions/D38/" rel="external"><strong>COST</strong>
									"Metal-based Systems for Molecular Imaging", 2006-2011 (Coord.)</a></li>
							<li><strong>EMMI</strong>("European Master in Molecular
								Imaging"), 2008</li>
						</ul>
						<!-- InstanceEndEditable -->
					</div>
					
					
				</div>
			</div>
			<!-- subsection closing -->
		</div>
		<!-- subsection closing -->
		<div id='after'></div>
		<div id='footer'>
			<p>
				Molecular Imaging Center - Via Nizza, 52 - I-10125 Torino - ITALY<br>
				Fax. Tel. Mail
			</p>
		</div>
		
		<!-- section closing -->
	</div>
	<!-- section closing -->
	<script type="text/javascript">
//
<![CDATA[
changeSideNavStyles();
//]]>
</script>
	<!-- InstanceEnd -->
</body>
</html>
